Estimation of Oxfendazole in Bulk and Pharmaceutical Formulation by Various Analytical Methods an Overview

Authors

  • Bhusari Vishwas M Research Scholar, Department of Pharmacy, Loknete Dadapatil Pharate College of Pharmacy, Mandavgan Pharata, Maharashtra, India
  • Kamble H Principal, Department of Pharmacy, Loknete Dadapatil Pharate College of Pharmacy, Mandavgan Pharata, Maharashtra, India
  • Sagade Vaibhav B Research Scholar, Department of Pharmacy, Loknete Dadapatil Pharate College of Pharmacy, Mandavgan Pharata, Maharashtra, India
  • Waghmare Santosh Professor, Department of Pharmacy, Loknete Dadapatil Pharate College of PharmacyMandavgan Pharata, Maharashtra, India

Keywords:

Oxfendazole, Method validation, Method development, Analytical Method, UV-Spectroscopic

Abstract

Mebendazole, albendazole, levamisole, and pyrantel pamoate, the most often used conventional therapies for soil transmitted helminths in humans, have very varied efficiency against different parasite species and have unfavourable pharmacokinetic properties, such as a short half-life. Oxfendazole, a strong broad-spectrum anthelmintic with a long half-life, has been regarded a promising method for transitioning from veterinary medicine to human use. Analytical approaches for quantitative detection of oxfendazole in human matrix, on the other hand, are limited and insensitive. Some bioanalytical methods were used to monitor oxfendazole according to literature survey, such as UV-Spectroscopic, Bioanalytical Method development of oxfendazole by UPLC-MS/MS. Mebendazole, albendazole, levamisole, and pyrantel pamoate, the most often used conventional therapies for soil transmitted helminths in humans, have inconsistent efficiency against different parasite species and have unfavourable pharmacokinetic properties, such as a short half-life. Oxfendazole, a strong broad-spectrum anthelmintic with a long half-life, has been deemed a promising method for moving from veterinary medicine to human use. Analytical approaches for detecting oxfendazole in human matrix, on the other hand, are quite limited and insensitive. All validation parameters were within the acceptable range. Very few methods for determination of oxfendazole have been reported.

References

Bach T, Bae S, D Cunha R, Winokur P, An G. Development and validation of a simple, fast, and sensitive LC/MS/MS method for the quantification of oxfendazole in human plasma and its application to clinical pharmacokinetic study. Journal of pharmaceutical and biomedical analysis. 2019; 171: 111–7.

Wikipedia. (2021, Nov.) Oxfendazole [Online]. Available from https://en.wikipedia.org/

wiki/Oxfendazole

Drug Bank Online. (2021, Feb.) Oxfendazole: Uses, Interactions, Mechanism of Action [Online]. Available from https://go.drugbank.com/drugs/DB11446

Keiser J, Utzinger J. Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. Jama. 2008; 299 (16): 1937–48.

PubChem (nih.gov). Oxfendazole C15H13N3O3S [Online]. Available from https://pubchem.

ncbi.nlm.nih.gov/compound/Oxfendazole#section=Classification

Papich MG. Saunders handbook of veterinary drugs. St. Louis, MO: Saunders Elsevier; 2007.

Nilesh S. Pendhbaje, Rupali V. Nirmal, Ashwini A. Jamdhade, Shain M. Pathan. A Review on Quantification of Brexpiprazole in Its Bulk and Pharmaceutical Dosage Form by Various Analytical Methods. International Journal of Pharmaceutical Research and Applications. 2021; 6 (1) pp: 1118–1132.

Pulusu VS, Routhu KC, Chikkaswamy SS. Quantitative determination of brexpiprazole by RP-HPLC method. Pharmaceutica Analytica Acta. 2019; 10 (2): 610.

Sabir, AM. HPLC method development and validation -a review. International Research Journal of Pharmacy. (2013); 4 (4): 39–46.

ICH Guideline Q2(R1) (1996) on Validation of Analytical Procedures: Text and Methodology, International Conference on Harmonization, Geneva, 6 Nov 1996, incorp. Nov 2005.

Nilesh S. Pendhbaje, Rupali V. Nirmal, Ashwini A. Jamdhade, Shain M. Pathan. Method Development and Validation by HPLC: A Brief Review. Research & Reviews: A Journal of Pharmaceutical Science. 2021; 12 (1): 27–39p

Jagdale AS, Pendbhaje NS, Nirmal RV, Bachhav PM, Sumbre DB. Development and validation of RP-HPLC method for estimation of brexpiprazole in its bulk and tablet dosage form using Quality by Design approach. Future Journal of Pharmaceutical Sciences. 2021; 7 (1): 1–2.

Salama FM, Attia K, Mohamad A, Said R, Madkour A. Development and Validation of Spectrophotometric Methods for Quantitative Estimation of Oxfendazole in Presence of Its Alkali-induced Degradation Product: A Comparative Study. Journal of Advanced Pharmacy Research. 2017; 1 (4): 176–84.

Shah G, Bradley D, Shek E. Liquid chromatographic determination of oxfendazole in swine feeds. Journal of the Association of Official Analytical Chemists. 1984; 67 (4): 707–9.

Downloads

Published

2022-03-23

Issue

Vol. 9 No. 1 (2022)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.